ArticleCurrent issues in molecular biology2022

Synthetic TGF-β Signaling Agonist-Treated Dendritic Cells Induce Tolerogenicity and Antirheumatic Effects.

Ji-Soo Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.